SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969
http://www.w3.org/2000/01/rdf-schema#comment
"c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma."
xsd:string
http://purl.uniprot.org/uniprot/#_027D3ADBEBBE8AC4598E2774DBD20D658D27F307EE5815DE46118B2E914691A58DF291A5B15542B7323B37B1E1141519
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969
http://purl.uniprot.org/uniprot/B3CJ88
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969
http://purl.uniprot.org/uniprot/#_B3CJ88-mappedCitation-32145111
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A65FA8D8B68A0989F3D9061AC5E37159D08C31062321362CD5AF44DDE6E9D27CF791A1AD5363CC73EAA9E4E3E900E969